Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dihydro-5-azacytidine

A synthetic nucleoside analogue of deoxycytidine. Dihydro-5-azacytidine inhibits DNA methyltransferase, thereby interfering with abnormal DNA methylation patterns that are associated with genetic instability in some tumor cells. Inhibition of this enzyme may restore expression of tumor-suppressor genes and result in antitumor activity.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Abbreviation:	DHAC
Chemical structure:	1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride 5,6-dihydro-5-azacytidine HCl 5,6-dihydro-5-azacytidine hydrochloride
IND number:	19672
NSC code:	264880

dihydro-5-azacytidine

Search NCI's Drug Dictionary